![](/img/cover-not-exists.png)
The Oral JAK / SYK Inhibitor ASN 002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate‐to‐Severe Atopic Dermatitis: Results from a Randomised, Double‐Blind, Placebo‐Controlled Study
Bissonnette, R., Maari, C., Forman, S., Bhatia, N., Lee, M., Fowler, J., Tyring, S., Pariser, D., Sofen, H., Dhawan, S., Zook, M., Zammit, D.J., Usansky, H., Denis, L., Rao, N., Song, T., Pavel, A.B.,Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.17932
Date:
March, 2019
File:
PDF, 792 KB
2019